`Indian pharma resilient to potential US tariffs’

Potential tariff on pharma imports into the US, while still under Section 232 investigation, is unlikely to impact the credit profiles of Indian pharma companies, India Ratings and Research (Ind-Ra) said.While the US contributes around 35% to the total revenue for leading domestic pharma companies, this proportion has been steadily declining over the past few…

Read More

Trump’s 50% tariffs: Indian refiners may trim Russian crude purchases; but India signals no plans to stop Russia oil trade

Indian refiners, who are major purchasers of Russian crude oil, intend to reduce their imports in the coming days. (AI image) Indian refiners’ crude oil procurement from Russia is set to reduce in the coming weeks, albeit modestly. The move comes at a time when the Donald Trump administration has imposed a 25% additional tariff…

Read More

US tariff blow: India’s readymade garments industry faces tough fiscal, says Crisil report; warns growth may slow to 3-5%

India’s readymade garment industry is bracing for a tough fiscal ahead, with revenue growth forecast to slow to just 3-5% over the period, nearly half the pace seen last year.This slowdown hurt credit indicators for industry players and led to weaker profitability, according to a recent report by Crisil Ratings. PM Modi’s Defiant ‘MAKE IN…

Read More